Treatment complications and survival in advanced laryngeal cancer: A population-based analysis

Laryngoscope

Volumn 124, Issue 12, 2014, Pages 2707-2713

  O'Neill, Caitriona B ^a,b   O'Neill, James P ^b   Atoria, Coral L ^a   Baxi, Shrujal S ^a,b   Henman, Martin C ^b   Ganly, Ian ^b   Elkin, Elena B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Complications; Laryngeal cancer; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; DYSPHAGIA; ESOPHAGITIS; ESOPHAGUS STENOSIS; EVIDENCE BASED PRACTICE; FEEDING APPARATUS; FEMALE; FUNCTIONAL STATUS; HUMAN; LARYNGECTOMY; LARYNX CANCER; LOW RISK PATIENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICARE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT SELECTION; PNEUMONIA; POPULATION RESEARCH; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SEPSIS; SURVIVAL PREDICTION; TRACHEOSTOMY; TREND STUDY; VENOUS THROMBOEMBOLISM; VERY ELDERLY; XEROSTOMIA; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGY; FOLLOW UP; INCIDENCE; IRELAND; LARYNGEAL NEOPLASMS; MORTALITY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TRENDS;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRELAND; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE;

EID: 84912066807     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24658     Document Type: Article

References (48)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. National Comprehensive Cancer Network. Head and Neck Cancers. NCCN Clinical Practice Guidelines in Oncology. v2. Fort Washington, PA: NCCN; 2011. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed April 27, 2014.
3. Chen AY, Fedewa S, Pavluck A, et al. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 2010;116:4744-4752.
4. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
5. Chen AY, Halpern M. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:1270-1276.
6. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006;135: 831-837.
7. Gourin CG, Conger BT, Sheils WC, et al. The Effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009;119:1312-1317.
8. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-962.
9. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:1-13.
10. Gourin CG, Frick KD. National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 2012;122:88-94.
11. Wolf G, Hong K, Fisher S, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-1690.
12. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008;26:3582-3589.
13. Michal SA, Adelstein DJ, Rybicki LA, et al. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head Neck 2012;34:1147-1152.
14. Francis DO, Weymuller EA Jr, Parvathaneni U, et al. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? Ann Otol Rhinol Laryngol 2010;119:391-397.
15. Davis GE, Schwartz SR, Veenstra DL, et al. Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg 2005;131:21-26.
16. Ganly I, Patel S, Matsuo J, et al. Postoperative complications of salvage total laryngectomy. Cancer 2005;103:2073-2081.
17. Bourhis JS, Le Maitre, Pignon J, et al. Impact of age on treatment effect in locally advanced head and neck cancer (HNC): two individual patient data meta-analyses. J Clin Oncol 2006;24 (suppl 18S):280s (abstract).
18. Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 2009;92:4-14.
19. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40: IV-3-18.
20. Greene FL, Page DL, Fleming ID, Fritz A, Bakch CM, Haller DG, Morrow M. eds. AJCC Cancer Staging Manual, 6th edition. New York, NY Springer; 2002.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-619.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
23. Rosenbaum PR. Optimal matching for observational studies. J Am Stat Assoc 1989;84:1024-1032.
24. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-763.
25. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.
26. Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006;24:2612-2617.
27. Maddox PT, Davies L. Trends in total laryngectomy in the era of organ preservation: a population-based study. Otolaryngol Head Neck Surg 2012;147:85-90.
28. Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 2012;34:270-281.
29. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
30. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003; 129:44-49.
31. Hamdan J, Feldman L. Survival after organ preserving treatment for T4a laryngeal squamous cell carcinoma. Ann Oncol 2010;21:2292-2293.
32. Wolf GT. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol 2010;28:2315-2317.
33. Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24: 3693-3704.
34. Weeks J, Pfister DG. Outcomes research studies. Oncology (Williston Park) 1996;10:29-34.
35. Groome PA, O'Sullivan B, Mackillop WJ, et al. Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada. Clin Oncol (R Coll Radiol) 2011;23:19-28.
36. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66:253-262.
37. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
38. Givens DJ, Karnell LH, Gupta AK, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2009;135:1209-1217.
39. Brizel DM, Lydiatt W, Colevas AD. Controversies in the locoregional management of head and neck cancer. J Natl Compr Canc Netw 2011;9:653-662.
40. Genden EM, Ferlito A, Rinaldo A, et al. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 2008;30:103-110.
41. Staton J, Robbins KT, Newman L, et al. Factors Predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002;127:43-47.
42. Newman LA, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:589-592.
43. DeSanto LW, Olsen KD, Perry WC, et al. Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol 1995;104: 763-769.
44. Williamson JS, Ingrams D, Jones H. Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study. Ann R Coll Surg Engl 2011;93:591-595.
45. Young VN, Mangus BD, Bumpous JM. Salvage laryngectomy for failed conservative treatment of laryngeal cancer. Laryngoscope 2008;118: 1561-1568.
46. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the radiation therapy oncology group trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129: 44-49.
47. Austin PC, Mamdani MM, Stukel TA, et al. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med 2005;24:1563-1578.
48. Potosky AL, Warren JL, Riedel ER, et al. Measuring complications of cancer treatment using the SEER-Medicare data. Med Care 2002;40:IV- 62-8.